Patent · US Active

Headless hemagglutin influenza vaccine

US11945841B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

Georgia State University Research Foundation · US

Inventors

Baozhong Wang · Duluth, US
Lei Deng · Hubei, CN

Key dates

Filing date	Oct 4, 2018
Grant date	Apr 2, 2024
Priority date	—
Expiry date	Nov 5, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16234
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are universal influenza based on a truncated influenza hemagglutin (HA) protein lacking a head domain (hrHA). Also disclosed is a composition comprising a nanoparticle coated with a disclosed hrHA polypeptide. Also disclosed is a composition comprising a virus like particle (VLP) expressing on its surface a disclosed hrHA polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.